Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myeloid, Accelerated Phase × blinatumomab × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Leukemia 8 Burkitt Lymphoma 8 Recurrence 7 Lymphoproliferative Disorders 6 Lymphatic Diseases 5 Lymphoma, Non-Hodgkin 4 Immunoproliferative Disorders 4 Neoplasm, Residual 3 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Lymphoid 2 Neoplasms by Histologic Type 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Large Granular Lymphocytic 1 Leukemia, Biphenotypic, Acute 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Bites and Stings 1

Interventions

fludarabine phosphate 26 Cyclophosphamide 23 Whole-Body Irradiation 21 Peripheral Blood Stem Cell Transplantation 20 Tacrolimus 19 Busulfan 19 Mycophenolic Acid 17 Antilymphocyte Serum 14 Melphalan 12 Methotrexate 11 Cyclosporine 9 Filgrastim 7 Etoposide 7 Cord Blood Stem Cell Transplantation 7 thymoglobulin 5 Sirolimus 5 Rituximab 5 Radiotherapy 5 Cytarabine 5 Thiotepa 4 Methylprednisolone 4 Granulocyte Colony-Stimulating Factor 4 fludarabine 3 Flow Cytometry 3 merphos 2 Polymerase Chain Reaction 2 Ondansetron 2 Imatinib Mesylate 2 Gene Expression Profiling 2 Dexamethasone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡